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Abstract
Safeguarding	cerebral	 function	 is	of	major	 importance	during	pediatric	anesthesia.	
Premature,	 ex‐premature,	 and	 full‐term	neonates	 can	be	vulnerable	 to	physiologi‐
cal	changes	that	occur	during	anesthesia	and	surgery.	Data	from	studies	performed	
during	pediatric	cardiac	surgery	and	in	neonatal/pediatric	intensive	care	units	have	
shown	the	benefits	of	near‐infrared	spectroscopy	(NIRS)	monitoring	of	regional	cer‐
ebral	oxygenation	 (c‐rSO2).	However,	NIRS	monitoring	 is	 seldom	used	during	non‐
cardiac	pediatric	anesthesia.	Despite	compelling	evidence	that	blood	pressure	does	
not	reflect	end‐organ	perfusion,	 it	 is	still	regarded	as	the	most	 important	determi‐
nant	of	cerebral	perfusion	and	the	most	relevant	hemodynamic	management	target	
parameter	by	most	(pediatric)	anesthetists.	The	principle	of	NIRS	monitoring	is	not	
self‐explanatory	and	sometimes	seems	even	counterintuitive,	which	may	explain	why	
many	anesthesiologists	are	reserved	regarding	its	use.	The	first	part	of	this	paper	is	
dedicated	 to	 a	 clinical	 introduction	 to	NIRS	monitoring.	Despite	 scientific	 efforts,	
it	has	not	yet	been	possible	to	define	 individual	 lower	 limit	c‐rSO2	values	and	 it	 is	
unlikely	this	will	succeed	in	the	near	future.	Nonetheless,	published	treatment	algo‐
rithms	usually	specify	c‐rSO2	values	which	may	be	associated	with	cerebral	hypoxia.	
Our	treatment	guideline	for	maintaining	sufficient	cerebral	oxygenation	differs	fun‐
damentally	 from	all	previously	published	approaches.	We	define	a	baseline	c‐rSO2 
value,	registered	in	the	awake	child	prior	to	anesthesia	induction,	as	the	lowest	ac‐
ceptable	limit	during	anesthesia	and	surgery.	The	cerebral	rSO2	 is	the	single	target	
parameter,	while	blood	pressure,	heart	rate,	PaCO2,	and	SaO2	are	major	parameters	
that	determine	the	c‐rSO2.	Cerebral	NIRS	monitoring,	interpreted	together	with	its	
continuously	available	contributing	parameters,	may	help	avoid	potentially	harmful	
episodes	of	cerebral	desaturation	in	anesthetized	pediatric	patients.
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1  | INTRODUC TION
Safeguarding	children's	brains	has	always	been	among	the	most	chal‐
lenging	targets	in	pediatric	anesthesia.	Recent	research	efforts	have	
mainly	focused	on	potential	anesthetic	drug‐induced	neurotoxicity	
and	 intermediate‐and/or	 long‐term	 neurodevelopmental	 outcome.	
Prospective	studies	published	to	date	have	found	now	no	evidence	
of	neurotoxicity	in	young	children,	after	a	single	exposure	to	anes‐
thetic	agents.1‐3	On	the	other	hand,	recent	papers	discussing	acute	
severe	brain	damage	associated	with	general	anesthesia,	particularly	
in	neonates	and	infants,	are	challenging	our	perception	of	safety	of	
our	current	practice	of	pediatric	anesthesia.4,5
In	 a	 case	 series,	McCann	 et	 al	 delineated	 the	 development	 of	
postoperative	encephalopathy	 in	 six	 infants,	where	periods	of	hy‐
potension	and/or	hypocapnia	may	have	contributed	to	 (prolonged)	
periods	of	cerebral	hypoperfusion.6
Despite	research	using	various	methods	to	determine	individual	
lower	 limits	of	blood	pressure	 (BP)	 in	 anesthetized	 infants	 to	pre‐
vent	them	from	anesthesia	associated	acute	brain	damage,7‐12	there	
is	still	no	consensus	regarding	safety	margins	of	BP	in	anesthetized	
infants.13
Many	pediatric	anesthetists	instinctively	link	cerebral	hypoper‐
fusion	with	 low	 blood	 pressure.	 However,	 arterial	 blood	 pressure	
(BP)	 is	 no	more	 than	one	of	 the	 factors	 contributing	 to	 the	main‐
tenance	 of	 cerebrovascular	 autoregulation	 and	 is	 not	 a	 surrogate	
for	cerebral	perfusion	or	tissue	perfusion	in	general	(see	Figure	1).	
Despite	 compelling	 evidence	 that	 BP	 does	 not	 reflect	 end‐organ	
perfusion,	it	 is	still	regarded	as	the	most	important	determinant	of	
cerebral	perfusion	by	most	(pediatric)	anesthetists.
Near‐infrared	spectroscopy	(NIRS)	is	a	non‐invasive	technology	
that	 provides	 real‐time	 information	 regarding	 tissue	 oxygenation.	
A	growing	body	of	evidence	emerging	from	pediatric	cardiac	anes‐
thesia	papers	suggests	that	NIRS	detected	cerebral	desaturation	is	
linked	to	bad	neurological	outcome.14,15	When	interpreted	together	
with	 standard	monitoring	 parameters,	 cerebral	 NIRS	 provides	 the	
anesthetist	with	 early	warning	 signs	 of	 impaired	 tissue	 perfusion,	
ventilation,	and	oxygenation,	allowing	one	to	draw	conclusions	as	to	
the	cause	16	and	subsequently	enabling	immediate	interventions	to	
prevent	the	child	from	potentially	life‐threatening	complications	or	
at	least	to	reduce	their	severity.17
While	it	has	become	a	standard	of	care	in	many	pediatric	cardiac	
centers	 and	 neonatology	 units,	NIRS	monitoring	 is	 not	 yet	widely	
applied	in	children	undergoing	noncardiac	surgical	procedures.	The	
majority	 of	 papers	 delineating	 the	 use	 of	NIRS	monitoring	 during	
major	noncardiac	pediatric	surgery	have	been	published	in	surgical	
journals.	In	these	pediatric	surgical	studies,	NIRS	was	often	used	as	
a	monitoring	tool	to	address	possible	safety	issues	of	new	surgical	
techniques,	 such	 as	 thoracoscopic	 repair	 of	 congenital	 diaphrag‐
matic	hernia	or	esophageal	atresia.18‐20
The	 aim	 of	 this	 article	 is	 threefold:	 Firstly,	we	 give	 a	 practical	
introduction	 to	 near‐infrared	 spectroscopy	 (NIRS)	 in	 pediatric	 pa‐
tients.	Secondly,	we	present	our	approach	to	managing	hemodynam‐
ics	and	maintaining	adequate	cerebral	perfusion/tissue	oxygenation,	
using	 regional	 cerebral	 tissue	 oxygenation	 (c‐rSO2)	 measured	 by	
NIRS	 as	 the	 central	 target	 parameter.	 Finally,	 we	 shall	 share	with	
you	our	thoughts	about	the	future	of	NIRS	monitoring	in	pediatric	
anesthesia.
2  | A PR AC TIC AL INTRODUC TION TO 
NE AR‐INFR ARED SPEC TROSCOPY (NIRS)
2.1 | The technical background of near‐infrared 
spectroscopy (NIRS)
NIRS	technology	applies	light	wavelengths	within	the	650‐1100	nm	
range,	the	so‐called	“optical	window”	for	measuring	tissue	oxygena‐
tion.	As	 opposed	 to	 ultraviolet,	 infrared,	 and	 visible	 light,	 near‐in‐
frared	 (NIR	 light)	 is	 not	 strongly	 absorbed	 by	 water,	 proteins	 or	
hemoglobin	and	scatters	less,	making	it	capable	of	providing	infor‐
mation	from	the	inner	body	after	analysis	of	its	spectrum.21
Within	the	NIR	spectrum,	photons	can	penetrate	tissue	several	
centimeters	and	even	penetrate	bone,	the	latter	being	a	prerequisite	
for	transcranial	NIRS	monitoring.22	NIRS	monitoring	provides	real‐
time	information	regarding	the	difference	between	tissue	oxyhemo‐
globin	and	deoxyhemoglobin,	 reflecting	tissue	oxygen	uptake,	and	
consumption.23
The	basic	principle	of	the	currently	commercially	available	med‐
ical	NIRS	devices	is	the	application	of	a	sensor	which	emits	2‐5	dif‐
ferent	wavelengths	of	light	within	the	NIR	spectrum	into	tissue.	The	
emitted	 photons	 are	 partly	 absorbed	 by	 optical	 pigments,	 among	
them	hemoglobin.	Depending	on	the	degree	of	oxygenation,	the	re‐
sultant	NIR	spectrum	changes	and	reflected	photons	are	returned	to	
the	 tissue	 surface	after	 reflection,	where	 superficial	NIR	 radiation	
detectors	are	 integrated	into	the	NIRS	sensor.	Device	manufactur‐
ers	 claim	 that	 specific	 algorithms	 remove	 the	 effect	 of	 superficial	
tissue,	referred	to	as	extracerebral	contamination.	However,	Kato	et	
al24	and	Davie	and	Grocott25	reported	significant	extracranial	con‐
tamination	in	adults	by	several	commercially	available	NIRS	devices.	
Kurth	et	al26	found	that	extracranial	contamination	is	unlikely	in	ne‐
onates,	infants,	and	young	children.
F I G U R E  1  Standard	continuous	anesthesia	monitoring	
parameters	contributing	to	cerebral	regional	oxygen	saturation	(c‐
rSO2)	[Colour	figure	can	be	viewed	at	wileyonlinelibrary.com]
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According	to	Ghosh	et	al,27	mitochondrial	cytochrome	c	oxidase	
(CCO),	being	responsible	for	>95%	of	oxygen	metabolism,	might	be	
a	more	important	chromophore	than	oxyhemoglobin	and	deoxyhe‐
moglobin,	and	probably	less	prone	to	extracerebral	contamination.	
Unfortunately,	currently	commercially	available	NIRS	monitors	have	
not	yet	integrated	CCO	in	their	algorithms.
Currently,	NIRS	 is	mostly	used	 to	monitor	 cerebral	 tissue	oxy‐
genation.	In	a	pediatric	study,	Watzman	et	al28	found	mean	arterial	
and	 venous	 contributions	 to	 c‐rSO2	 of	 16	 ±	 21%	 and	 84	 ±	 21%,	
respectively.	 Manufacturers	 have	 integrated	 algorithms	 into	 their	
monitors	which	assign	70%‐75%	of	the	scanned	blood	volume	to	the	
venous	compartment.29	This	does	not	mean	that	current	NIRS	mon‐
itors	 are	 capable	 of	measuring	 arteriovenous	 partitioning.	 In	 their	
2014	review	article,	Scott	and	Hoffman30	describe	NIRS	monitoring	
as	a	 tool	providing	 “non‐invasive	continuous	access	 to	 the	venous	
side	of	regional	circulations.”
The	 measurements	 reported	 by	 the	 current	 NIRS	 devices	 are	
expressed	 by	 the	 device	 manufacturers	 as	 either	 regional	 oxy‐
gen	 saturation	 rSO2	 or	 tissue	 oxygenation	 index	 TOI,
31 which are 
both	 expressions	 of	 the	 percentage	 of	 tissue	 oxyhemoglobin.	
Unfortunately,	 in	the	scientific	 literature	many	other	abbreviations	
can	be	found,	such	as	StO2,	ScO2,	and	SctO2;	actually,	all	of	them	are	
expressions	of	regional	tissue	oxygenation	but	this	inconsistency	in	
reporting	creates	more	confusion.
2.2 | Parameters contributing to c‐rSO2
Physiological	parameters	known	to	contribute	to	the	cerebral	oxy‐
gen	 delivery/demand	 balance	 need	 to	 be	 considered	 as	 relevant	
when	interpreting	c‐rSO2.	Oxygen	delivery	to	the	brain	is	basically	
a	function	of	cardiac	output,	perfusion	pressure,	oxygenation,	and	
hemoglobin	concentration.	Oxygen	demand	is	furthermore	related	
to	 the	 cerebral	metabolic	 rate	 (CMR)	which	 is	 reduced	 by	 all	 cur‐
rently	used	anesthetic	drugs	except	ketamine,	which	causes	a	 rise	
in	CMR.32
(Pediatric)	anesthetists	traditionally	rely	on	standard	monitoring	
parameters	like	blood	pressure,	heart	rate,	pulse	oximetry	to	assess	
their	patient's	cardiocirculatory	and	respiratory	status.
Continuous	 (non‐invasive)	 measurement	 of	 cardiac	 output,	
though	technically	possible,33,34	has	not	yet	become	common	prac‐
tice	 in	 pediatric	 anesthesia.	A	 growing	body	of	 evidence	 suggests	
that	arterial	blood	pressure,	though	not	a	good	estimate	of	cerebral	
perfusion,	seems	to	contribute	mostly	to	changes	in	c‐rSO2.
35	Heart	
rate	is	also	important,	especially	in	neonates	and	young	infants.
The	 arterial	 carbon	 dioxide	 tension	 (PaCO2)	 also	 significantly	
contributes	to	cerebral	blood	flow	with	hypocarbia	resulting	in	ce‐
rebral	vasoconstriction	and	reduced	cerebral	blood	flow	and	hyper‐
carbia	resulting	in	vasodilation	and	increased	cerebral	blood	flow.	In	
a	pediatric	study,	de	Waal	et	al	could	show	that	increasing	the	PaCO2 
from	32	to	40	mm	Hg	in	anesthetized	patients	resulted	in	an	increase	
in	c‐rSO2	from	61%	to	70%.
36
The	arterial	 oxygen	 tension	 (PaO2)	 appears	 to	 contribute	 to	 c‐
rSO2	to	a	lesser	degree	than	PaCO2 
37	but	should	be	considered	as	
well,	especially	during	acute	hypoxic	events.
Anemia	 becomes	 relevant	 for	 c‐rSO2	 when	 hemoglobin	 levels	
are	 too	 low	to	deliver	an	oxygen‐carrying	capacity	 that	meets	 the	
demands	of	cerebral	oxygen	consumption.	Under	these	conditions,	
transfusion	of	red	blood	cells	has	been	shown	to	result	in	increased	
c‐rSO2	values.
38	It	should	be	kept	in	mind	that	in	a	surgical	setting,	
a	decrease	in	c‐rSO2	can	be	due	to	low	hemoglobin	concentrations	
following	acute	blood	loss	even	before	decreases	in	blood	pressure	
occur.
Other	physiological	parameters,	such	as	body	temperature	and	
blood	glucose	level,	also	contribute	to	cerebral	perfusion.	If	possible,	
any	parameter	measured	should	be	kept	within	its	age‐related	and/
or	patient‐specific	physiologic	range.
As	opposed	to	the	cardiorespiratory	monitoring	parameters,	we	
are	used	to	rely	on,	such	as	heart	rate,	blood	pressure,	oxygen	sat‐
uration,	and	carbon	dioxide	partial	pressure,	a	c‐rSO2	value	is	not	a	
“stand‐alone”	parameter;	it	is	more	or	less	the	ultimate	expression	of	
the	interplay	between	the	aforementioned	contributing	parameters	
(see	Figure	1).	The	course	of	a	NIRS	reading	should	therefore	always	
be	interpreted	in	the	context	of	the	course	(and	the	possible	changes)	
of	the	factors	contributing	to	it.	In	a	recent	editorial,	Skowno	et	al14 
referred	to	NIRS	as	a	“multidimensional	monitor”	enabling	the	inter‐
pretation	of	multiple	variables	influencing	cerebral	blood	flow.
2.3 | NIRS monitoring in children under chronic 
hypoxemic conditions
A	closer	look	at	NIRS	monitoring	in	children	with	cyanotic	heart	dis‐
ease	nicely	illustrates	the	fundamental	difference	between	NIRS	and	
pulse	oximetry.39,40	While	the	pulse	oximeter	shows	an	oxygen	satu‐
ration	of	85%,	NIRS‐derived	c‐rSO2	values	are	around	70%,	equal‐
ing	the	range	usually	seen	in	awake	healthy	children	with	an	oxygen	
saturation	of	±98%.	This	equality	in	c‐rSO2	values	can	easily	be	ex‐
plained	by	the	pathophysiology	of	cyanotic	heart	disease:	In	order	to	
compensate	for	a	 low	arterial	oxygen	saturation,	secondary	eryth‐
rocytosis	 develops	 resulting	 in	 significantly	 elevated	 hemoglobin	
levels	 and	 an	 (almost)	 normal	 oxygen	 delivery	 capacity.	 The	 brain	
extracts	the	same	amount	of	oxygen	as	in	healthy	children,	but	from	
more	hemoglobin	molecules	in	the	same	blood	volume,	resulting	in	
normal	venous	oxygen	saturation	and	c‐rSO2	values.	This	principle	
applies	 to	 pediatric	 cardiac	 patients	 with	mild	 chronic	 hypoxemia	
(SaO2	±	85%)	but	probably	not	to	patients	under	more	extreme	hy‐
poxemic	conditions.
In	this	context,	it	seems	sensible	to	mention	that	pulse	oximeters,	
undisputed	core	elements	of	our	standard	monitoring,	already	begin	
to	overrate	SaO2	under	mild	hypoxemic	conditions	(SaO2	<	90%).	This	
error	 further	 increases	with	 increasing	 hypoxemia.41	Nonetheless,	
most	of	us	erroneously	accept	the	values	of	the	pulse	oximeter,	no	
matter	how	low	they	are.
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2.4 | NIRS—common misconceptions
NIRS	monitoring	is	still	widely	misunderstood	because	it	is	often	mis‐
takenly	compared	to	pulse	oximetry.	Pulse	oximetry	is	dependent	on	
pulsatile	blood	flow,	designed	to	measure	the	fraction	of	oxygenated	
arterial	blood.	NIRS	monitoring	does	not	depend	on	pulsatile	blood	
flow	and	provides	information	about	the	tissue	oxyhemoglobin/de‐
oxyhemoglobin	ratio.	To	make	a	clear	distinction	from	pulse	oxime‐
try,	NIRS	can	probably	best	be	described	as	a	nonpulsatile	venous	
oximeter.	 When	 interpreted	 together	 with	 pulse	 oximetry,	 NIRS	
monitoring	 provides	 information	 regarding	 tissue	 oxygen	 delivery	
and	consumption.
High	c‐rSO2	values	can	be	misleading	under	certain	conditions.	
In	 our	 own	 institution,	we	 commonly	 see	 exceptional	 high	 c‐rSO2 
values	 (±90%)	 in	 ventilated	 ICU	patients	 sedated	with	midazolam,	
especially	 in	neonates	 and	young	 infants.	After	discontinuation	of	
midazolam	and	subsequently	decreasing	midazolam	blood	concen‐
trations,	c‐rSO2	values	usually	decline	to	±70%	within	several	hours,	
due	to	an	increase	in	cerebral	metabolism.	This	observation	empha‐
sizes	 the	 importance	 of	 an	 initial	 baseline	 value,	 preferably	 under	
awake	conditions,	without	any	sedative	drug	effect.
2.5 | Improper use of medical NIRS devices—More 
than just kidneys and vegetables
A	recent	provocatively	humorous	paper	by	Kahn	et	al,42	published	
in	the	Christmas	issue	of	the	European	Journal	of	Anaesthesiology,	
comparing	NIRS	 in	 vegetables	 and	humans	 is	 certainly	 one	of	 the	
most	extreme	examples	of	 improper	use	of	medical	NIRS	technol‐
ogy.	Though	certainly	not	meant	to	be	regarded	as	serious	research	
by	 the	 authors,	 this	 paper	 carries	 the	 risk	 of	 perpetuating	 foolish	
misunderstandings	of	how	medical	NIRS	devices	work.	However,	it	is	
easy	to	explain	why	vegetables	can	have	NIRS	measurements	com‐
parable	to	humans:	Many	sorts	of	vegetables	contain	chromophores	
with	optical	properties	comparable	to	hemoglobin.43	A	medical	NIRS	
device,	when	attached	to	these	vegetables,	receives	information	via	
its	 sensor	which,	 according	 to	 the	device	 algorithm,	 is	 interpreted	
as	derived	from	hemoglobin,	resulting	in	a	“normal”	NIRS	value.	It	is	
also	worth	noting	that	designated	NIRS	technology	has	a	 long	his‐
tory	in	food	safety	evaluation	and	control.44
Wallin	and	Lönnqvist	recently	eloquently	elaborated	the	risk	of	
unintentional	 improper	 use	 of	 medical	 NIRS	 devices45:	 Currently,	
commercially	 available	 NIRS	 monitors	 have	 their	 algorithms	 pro‐
grammed	 to	 exclude	 the	most	 superficially	 reflected	photons,	 be‐
cause	 they	 represent	 bone	 or	 cartilage	 tissue	 rather	 than	 brain	
tissue.	Using	NIRS	sensors	designed	for	brain	monitoring	for	moni‐
toring	somatic	tissue	oxygenation	(where	there	is	no	superficial	bone	
layer)	may	 result	 in	 invalid	NIRS	values.	Fortunately,	NIRS	devices	
with	 specific	 somatic	 measurement	 algorithms	 have	 recently	 be‐
come	available	for	routine	clinical	use.
The	distance	between	 the	 light	 source	 and	 the	 light	 detecting	
optode	of	 a	NIRS	 sensor	 is	 another	 potential	 source	 of	 error	 that	
many	users	are	unaware	of.	Dix	et	al	 found	significant	differences	
in	c‐rSO2	values	in	preterm	neonates	measured	with	different	NIRS	
sensors.46	Kleiser	et	al	investigated	the	impact	of	the	source‐detec‐
tor	separation	(SDS)	of	several	commercially	available	NIRS	sensors	
on	their	performance47,48	and	reported	different	tissue	oxygenation	
values	 measured	 by	 different	 device‐sensor	 combinations	 in	 the	
same	neonatal	head	phantom.	According	 to	Wallin	 and	Lönnqvist,	
currently	 available	 neonatal	 cerebral	 NIRS	 sensors	 should	 not	 be	
used	in	neonates	<2.5	kg,	because	due	to	the	small	size	of	the	head	
of	these	tiny	infants	it	would	be	likely	that	the	resulting	c‐rSO2 val‐
ues	would	 represent	white	matter	or	 lateral	ventricle	oxygenation	
rather	than	a	cortical	trace.45
2.6 | The ongoing search for c‐rSO2 normal 
values and lower limits of safety
According	to	a	recent	meta‐analysis	published	by	Chan	et	al,	normal	
awake	c‐rSO2	baseline	value	in	adults	range	from	51%	to	81.8%,	with	
a	pooled	mean	of	66.4%.49	c‐rSO2	reference	ranges	have	also	been	
described	for	term	and	preterm	and	small	for	gestational	age	neo‐
nates,	with	means	between	±65%	and	±70%.50,51	Unfortunately,	we	
are	not	aware	of	published	awake	c‐rSO2	baseline	data	applicable	to	
older	infants	or	children.	Many	pediatric	anesthetists	consider	a	c‐
rSO2	value	of	approximately	25%	less	than	the	actual	arterial	oxygen	
saturation	as	normal.	This	heuristic	approach,	almost	entirely	based	
on	 (personal)	experience,	ultimately	resulted	 in	some	kind	of	com‐
mon	sense.
The	 exact	 individual	 lower	 safety	 margin	 of	 c‐rSO2	 values	 in	
anesthetized	children	 is	yet	unknown.	Early	animal	data	published	
by	Kurth	et	al52	found	cerebral	hypoxia‐ischemia	c‐rSO2	thresholds	
between	33%	and	44%	for	acute	brain	energy	failure	and	brain	met‐
abolic	 dysfunction.	 Another	 animal	 study	 performed	 by	 Kurth	 et	
al53	 showed	 that	brain	 tissue	 injury	depends	on	both	severity	and	
duration	of	 ischemia.	As	severity	or	duration	of	 ischemia	 increase,	
the	degree	of	damage	increases.	In	piglets	subjected	to	a	c‐rSO2	of	
45%	from	1	to	8	hours	and	subsequently	recovered,	brain	injury	by	
histologic	and	behavioral	examination	was	not	evident	until	2	hours	
c‐rSO2	45%;	 then,	 the	 incidence	of	brain	 injury	 increased	15%	per	
hour,	 such	 that	 by	8	 hours	 c‐rSO2	 45%,	 all	 piglets	 displayed	brain	
injury.
In	neonates	after	Norwood	stage	I	palliation	for	hypoplastic	left	
heart	syndrome	(HLHS)	Dent	et	al54	found	an	association	between	
postoperative	c‐rSO2	values	<45%	lasting	longer	than	3	hours	and	
the	development	of	new	or	worsened	cerebral	 ischemic	lesions	on	
MRI	scans.	More	recent	research	 in	 infants	after	Norwood	stage	 I	
palliation	for	HLHS	has	shown	that	 in	this	particular	patient	popu‐
lation	NIRS‐derived	c‐rSO2	values	are	 insensitive	predictors	of	ce‐
rebral	venous	oxygen	saturation	values	of	<30%,	which	are	known	
to	 represent	 the	 anaerobic	 threshold.55	 The	 authors	 of	 this	 study	
specifically	concluded	that	even	c‐rSO2	values	>50%	are	not	neces‐
sarily	reassuring.
Pellicer	 et	 al	 recommended	 a	 nonindividualized	 c‐rSO2	 target	
range	 between	 55%	 and	 58%	 for	 extremely	 premature	 infants,56 
which	was	intended	to	avoid	both	cerebral	hypoxia	and	hyperoxia.	
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Stolwijk	et	al	adopted	this	recommendation	 in	a	case	series	of	ne‐
onates	 undergoing	 thoracoscopic	 repair	 of	 long	 gap	 esophageal	
atresia	and	added	an	individual	feature	to	it	by	trying	to	avoid	fluctu‐
ations	in	c‐rSO2	of	more	than	20%	from	baseline.
57
Until	now,	a	consensus	regarding	a	 lower	 limit	of	NIRS‐derived	
c‐rSO2	 values,	 serving	 as	 an	 intervention	 threshold,	 could	 not	 be	
reached.
2.7 | Limitations of cerebral NIRS monitoring
There	are	clinical	situations	in	which	NIRS	values	are	difficult	to	in‐
terpret.	An	almost	classic	scenario	 is	connecting	the	NIRS	monitor	
intraoperatively	at	the	moment	the	patient's	conditions	begin	to	de‐
teriorate	(ie,	low	blood	pressure,	low	SaO2,	etc).	As	we	do	not	have	
validated	 nonindividualized	 lower	 c‐rSO2	 safety	margins	 available,	
in	 these	 cases	 interpretation	 of	NIRS	 values	 is	 problematic,	 apart	
from	extremes;	that	is	a	c‐rSO2	value	of	30%,	usually	accompanied	
by	 a	 low	 SaO2‐value	 is	 without	 any	 doubt	 an	 urgent	 call	 for	 ac‐
tion,	whereas	a	c‐rSO2	value	of	85%	speaks	for	a	sufficient	cerebral	
oxygenation.	However,	without	knowledge	of	the	individual	awake	
baseline	c‐rSO2	value	it	is	difficult,	if	not	impossible	to	draw	a	mean‐
ingful	conclusion	as	to	a	c‐rSO2	value	of	for	example		±60%.
2.8 | NIRS and patient outcome
Cerebral	NIRS	monitoring	has	been	used	in	pediatric	cardiac	anes‐
thesia	 for	more	 than	 two	decades.	While	some	centers	 integrated	
c‐rSO2	 monitoring	 into	 their	 clinical	 protocols	 of	 perioperative	
hemodynamic	 management,	 others	 decided	 not	 to	 rely	 on	 NIRS	
monitoring.	Today,	there	is	little	doubt	as	to	the	predictive	value	of	
NIRS	monitoring	with	regard	to	early	outcome	after	pediatric	cardiac	
surgery.15,17
As	opposed	to	pediatric	cardiac	patients,	few	data	are	available	
regarding	NIRS	monitoring	and	outcome	after	pediatric	noncardiac	
surgery.	Olbrecht	et	al	published	an	observational	multicenter	study	
in	453	infants	<6	months	receiving	anesthesia	for	noncardiac	surgical	
procedures	and	found	a	43%	incidence	of	mild	cerebral	desaturation	
measured	by	NIRS,	whereas	the	incidences	of	usually	short	periods	
of	severe	cerebral	desaturation	were	as	 low	as	1.55%	for	absolute	
c‐rSO2	values	<50%	and	0.95%	for	a	30%	decline	from	baseline.
58 In 
this	study,	low	mean	blood	pressure	values,	though	common,	were	
not	well	associated	with	low	c‐rSO2	values.	The	authors	concluded	
that	severe	cerebral	deoxygenation	is	uncommon	in	noncardiac	in‐
fant	anesthesia.	In	a	recent	observational	study	performed	in	pediat‐
ric	noncardiac	surgical	patients,	Gomez‐Pesquera	et	al59	found	that	
a	 decrease	 of	 intraoperative	 c‐rSO2	 values	 of	 less	 than	20%	 from	
awake	baseline	was	associated	with	negative	behavioral	changes	on	
postoperative	day	7.
Large	 scale	 pediatric	 anesthesia	 studies	 addressing	 NIRS	 and	
neurodevelopmental	outcome	are	 still	 lacking,	both	 in	cardiac	and	
noncardiac	patients.
In	a	2011	review	article,	Greisen	et	al	estimated	that	a	trial	with	
sufficient	power	to	detect	a	20%	reduction	of	the	incidence	of	brain	
injury	 in	 extreme	 premature	 neonates	 should	 recruit	 about	 4000	
patients.60	 A	 recent	 international	 phase	 II	 feasibility	 randomized	
clinical	trial	in	160	extremely	preterm	infants	showed	a	reduction	in	
cerebral	hypoxic	events	due	to	a	NIRS‐guided	treatment	protocol56 
but	failed	to	detect	any	effect	on	the	occurrence	of	early	biomarkers	
of	 brain	 injury	 or	 EEG	burst	 rates61	 and	 neurodevelopmental	 out‐
come	at	2	years	of	age.62	In	this	neonatal	ICU	trial,	only	one	interven‐
tion	to	normalize	c‐rSO2	values	was	allowed	at	a	time	and	the	patient	
was	re‐assessed	30‐60	minutes	later.	Transient	anticipated	changes	
in	c‐rSO2	values	due	to	routine	interventions	(ie,	endotracheal	tube	
suctioning)	were	not	listed	in	the	treatment	protocol.	A	subsequent	
trial,	aiming	to	recruit	1600	patients,	has	been	designed	by	the	same	
consortium	to	investigate	the	possible	impact	of	their	NIRS	protocol	
on	the	incidence	of	death	or	severe	brain	injury	at	36	weeks.63
3  | NIRS‐DIREC TED HEMODYNAMIC 
MANAGEMENT: THE BA SELINE‐
BOT TOMLINE APPROACH
We	fully	agree	with	Scott	and	Hoffman	stating	that	“NIRS	opens	a	
window	for	regional	circulation	monitoring	that	can	drive	organ‐spe‐
cific	goal‐directed	treatments”.30	It	is	furthermore	currently	widely	
accepted	 that	 NIRS‐derived	 c‐rSO2	 is	 a	 reliable	 non‐invasive	 sur‐
rogate	 parameter	 of	 the	 cerebral	 oxygen	 supply/demand	 balance.	
Other	 parameters,	 among	which	 blood	pressure,	 heart	 rate,	 SaO2,	
and PaCO2,	 significantly	contribute	to	cerebral	perfusion,	but	 they	
provide	no	good	estimate	of	cerebral	perfusion.	Simultaneous	inter‐
pretation	 of	NIRS	 and	 contributing	 parameters	 currently	 provides	
us	with	the	most	reliable	information	regarding	the	cerebral	oxygen	
supply/demand	balance.14,16	As	a	consequence,	our	strategy	to	en‐
sure	adequate	cerebral	perfusion	and	oxygen	delivery	uses	cerebral	
rSO2	as	the	single	target	parameter,	while	BP,	heart	rate,	PaCO2,	etc	
are	contributors	serving	rSO2.
It	may	appear	somewhat	counterintuitive	to	recommend	the	use	
of	a	parameter	(c‐rSO2)	which	comes	short	of	a	clearly	defined	nor‐
mal	range	as	the	central	target	parameter	of	hemodynamic	manage‐
ment.	Worse	still,	there	are	also	no	generally	accepted	intervention	
targets	for	low	c‐rSO2	values.	Finally,	c‐rSO2	values	are	device	spe‐
cific.46‐48	However,	we	do	not	regard	these	points	as	a	shortcoming,	
as	long	as	it	is	possible	to	obtain	an	individual	c‐rSO2	baseline	value,	
measured	under	awake	conditions.	Awake	 is	 the	magic	word	here:	
We	assume	that	as	long	as	the	child	is	awake	and	responsive,	cere‐
bral	perfusion	and	oxygenation	are	both	sufficient.
This	clearly	puts	a	strong	case	for	handling	an	individualized	c‐
rSO2	target	for	children	under	anesthesia	conditions.	The	key	to	our	
concept	 is	 to	keep	 the	child's	cerebral	oxygenation	within	a	 range	
of	c‐rSO2	values	which	we	know	to	be	safe,	which	means	higher	than	
awake	baseline,	 instead	of	 allowing	 the	c‐rSO2	 to	decline	until	we	
begin	to	feel	uneasy	with	the	child's	condition.	Basically,	we	are	aim‐
ing	at	maintenance	of	an	optimal	condition	rather	than	treatment	of	
potentially	harmful	cerebral	desaturation.	We	call	this	strategy	our	
Baseline‐Bottomline	approach.	Contrary	to	the	treatment	guideline	
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developed	by	the	SafeBooS‐C	research	consortium,56	we	take	into	
account	any	change	of	the	c‐rSO2	under	anesthesia	conditions	with	
a	focus	on	immediate	restoration	of	normal	values.
Our	clinical	 approach	 to	NIRS‐directed	hemodynamic	manage‐
ment	 is	 quite	 straight	 forward:	 The	 child	 is	 attached	 to	 the	NIRS	
monitor	prior	 to	 induction	of	anesthesia	 to	obtain	an	awake	base‐
line	 value.	 This	 baseline	 value	 is	 considered	 to	 reflect	 adequate	
cerebral	 oxygenation.	 If	 possible,	 we	 measure	 an	 awake	 baseline	
blood	pressure	and	baseline	values	of	heart	rate	and	pulse	oximetry.	
Unfortunately,	it	is	not	always	possible	to	obtain	an	awake	baseline	
blood	pressure.12	Contrary	to	this	awake	blood	pressure	 issue,	we	
cannot	remember	a	single	patient	where	it	was	not	possible	to	obtain	
an	awake	baseline	c‐rSO2	value.	Our	experience	is	that	c‐rSO2 val‐
ues	usually	stabilize	within	<1	minute.	If	an	infant	is	upset	before	in‐
duction	of	anesthesia,	we	usually	see	baseline	c‐rSO2	values	slightly	
lower	than	in	calm	infants.	A	possible	explanation	for	this	phenome‐
non	is	the	increased	intrathoracic	pressure	during	crying,	resulting	in	
a	decreased	jugular	venous	return	causing	a	relative	increase	of	the	
cerebral	venous	compartment.	Unfortunately,	we	are	unable	to	com‐
ment	on	baseline	c‐rSO2	values	in	asleep	infants	because	application	
of	the	NIRS	sensor	usually	wakes	them	up.
During	 induction	 of	 anesthesia,	 immediately	 after	 loss	 of	 con‐
sciousness,	 an	 increase	 in	 c‐rSO2	 of	 at	 least	5%‐10%,	due	 to	a	 re‐
duction	in	cerebral	metabolism,	is	mandatory.	If	c‐rSO2	values	drop	
during	induction,	the	child	is	either	not	adequately	ventilated	and/
or	blood	pressure	has	dropped	significantly	due	to	anesthetic	drug	
effect	on	the	cardiocirculatory	system.	NIRS	values	react	very	fast,	
usually	 significantly	 faster	 than	 standard	 monitoring	 parameters,	
serving	both	as	an	early	warning	sign	and	as	an	immediate	feedback	
tool	 for	 any	 interventions	aiming	 to	 improve	 the	cerebral	oxygen‐
ation.	During	maintenance	of	anesthesia,	c‐rSO2	values	are	usually	
slightly	lower	than	during	the	induction	period,	but	still	above	awake	
baseline,	likely	a	result	of	higher	inspired	fraction	of	oxygen	during	
induction	 compared	 to	 the	maintenance	period.	Reduced	 cerebral	
metabolism	under	anesthesia	maintenance	conditions	usually	results	
in	 c‐rSO2	 values	 slightly	 (±5%‐10%)	higher	 than	 awake	baseline.	A	
flowchart	 (Figure	2)	 illustrates	our	 concept.	A	decline	 in	BP	 is	 the	
most	common	cause	of	a	drop	of	c‐rSO2	values.
35	It	is	a	key	feature	
of	our	Baseline‐Bottomline	approach	that	we	do	not	accept	c‐rSO2 
values	lower	than	or	equal	to	awake	baseline.	When	c‐rSO2	values	
approach	awake	baseline,	we	immediately	investigate	the	course	of	
our	predefined	contributing	factors	(BP,	PaCO2,	HR,	SaO2).	In	case	of	
a	decrease	in	BP,	we	start	a	continuous	infusion	of	norepinephrine	
(10	µg/mL),	in	the	first	instance	at	a	rate	of	0.1	µg/kg/min,	adminis‐
tered	through	a	peripheral	venous	catheter,	which	in	our	experience	
will	not	result	in	severe	hypertension.
Preoperative	 fluid	 deficits	 should	 also	 be	 compensated,	 but	 in	
our	experience	a	fluid	bolus	alone	is	seldom	enough	to	re‐establish	
baseline	 c‐rSO2	 values.	 Additional	 fluid	 boli,	 especially	 in	 preterm	
neonates,	come	with	an	 increased	risk	of	postoperative	fluid	over‐
load,	which	can	lead	to	respiratory	compromise.
Having	used	the	Baseline‐Bottomline	approach	 in	several	hun‐
dred	patients,	intraoperative	c‐rSO2	can	be	maintained	at	or	above	
baseline,	 regardless	 of	 circumstances,	 including	 epidural	 analgesia	
and	anesthetic	drug	effects	on	vascular	tone	and/or	cardiac	output	
in	almost	all	patients.
In	 our	 institution,	 we	 currently	 use	 cerebral	 NIRS	 monitoring	
in	noncardiac	 surgical	neonates	and	other	patients	assumed	 to	be	
at	high	risk	of	 impaired	cerebral	perfusion	during	the	course	of	an	
anesthetic,	 including	 the	 period	 before	 surgical	 incision	 and	 the	
emergence	period.	While	NIRS	monitoring	in	(preterm)	neonates	has	
become	a	standard	of	care	in	our	institution,	we	do	not	yet	have	a	
clinical	 guideline	as	 to	 the	 indication	 for	NIRS	monitoring	 in	older	
children.	 In	 our	 hospital,	 the	 decision	 to	 restrict	 the	 use	 of	 NIRS	
monitoring	to	patients	assumed	to	be	at	an	increased	risk	of	anes‐
thesia	associated	hypoxic‐ischemic	neurologic	 injury	is	mainly	eco‐
nomically driven.
In	 terms	of	 evidence‐based	medicine,	 our	Baseline‐Bottomline	
approach	 is	 no	more	 than	 a	 level	 III	 recommendation.	 It	may	 also	
be	 regarded	as	 too	 conservative.	Critics	may	 argue	 that	 there	 are	
no	 scientific	 data	 supporting	 our	 strategy,	 which	 is	 not	 entirely	
correct:	Olbrecht	 et	 al58	 recently	 reported	 frequent	 low	 (baseline	
−20%)	cerebral	desaturations	measured	by	NIRS	during	 infant	and	
neonatal	anesthesia,	while	Gomez‐Pesquera59	found	an	association	
of	decreases	in	c‐rSO2	values	of	<20%	with	negative	postoperative	
behavior	changes	on	postoperative	day	7.	The	logical	conclusion	of	
these	findings	is	that	even	moderate	declines	in	c‐rSO2	values	may	
have	a	negative	 impact	on	patient	wellbeing	and	should	 therefore	
be avoided.
NIRS	monitoring	remains	a	controversial	issue,	and	in	the	pedi‐
atric	 anesthesia	 community,	 there	 are	 both	 NIRS	 enthusiasts	 and	
F I G U R E  2  NIRS	direct	hemodynamic	management—the	
“Baseline‐Bottomline	approach”	[Colour	figure	can	be	viewed	at	
wileyonlinelibrary.com]
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sceptics.	Even	 in	our	own	 institution,	not	all	pediatric	anesthetists	
rely	 on	NIRS	monitoring.	Being	NIRS	 enthusiasts,	we	have	 to	 dis‐
close	a	bias	in	favor	of	the	use	of	NIRS	monitoring	in	pediatric	pa‐
tients,	while	we	tried	to	adequately	address	the	relevant	limitations	
and	 shortcomings	 of	 this	 technology	 There	 is	 an	 urgent	 need	 for	
more	 independent	 scientific	 data	 on	NIRS	monitoring	 in	 anesthe‐
tized	children.	Our	 research	group	at	Sophia	Children's	Hospital	 is	
currently	conducting	several	clinical	studies	on	NIRS	monitoring	in	
neonates	and	infants.
4  | THE FUTURE: MULTISITE NIRS 
MONITORING AND COMPOSITE 
PAR AMETERS
Simultaneous	application	of	NIRS	probes	on	the	forehead	and	other	
regions	of	the	body,	usually	referred	to	as	multisite	NIRS	monitoring	
is	becoming	increasingly	popular,	at	least	in	research	settings.
Renal	 rSO2	 values	 simultaneously	 recorded	 with	 c‐rSO2 may 
provide	 relevant	additional	 information	 regarding	 renal	 function.30 
Muscle	rSO2	values	also	simultaneously	recorded	with	c‐rSO2 have 
been	used	as	early	markers	of	centralization	of	the	circulation	in	pre‐
mature	neonates.64
Fractional	 regional	 tissue	 oxygen	 extraction	 [FTOE	 =	 (SaO2‐
rSO2)/SaO2]	 is	 a	 composite	 parameter	 reflecting	 the	 balance	 be‐
tween	oxygen	delivery	and	consumption,20,65,66	which	is	becoming	
increasingly	 popular	 in	 the	 neonatal	 ICU	 setting.	 Until	 now,	 the	
FTOE	 needs	 to	 be	 calculated	 manually.	 Such	 a	 calculation	 would	
distract	 the	 anesthetist's	 attention	 in	 the	 short	 term,	which	 could	
be	 an	 additional	 risk	 to	 the	patient.	NIRS	 technology	 is	 still	 being	
developed	by	the	device	manufacturers.	Algorithms	are	updated	to	
diminish	 the	 amount	 of	 extracerebral	 contamination	 and	 improve	
the	performance	of	somatic	NIRS	measurements.	Furthermore,	 in‐
tegration	with	 standard	 anesthesia	monitoring	 is	 slowly	 emerging	
and	hopefully	automated	calculations	of	composite	parameters,	for	
example	FTOE	will	soon	become	available.
Integration	 of	 other	 emerging	 technologies	 into	 the	 hemody‐
namic	 management	 workflow,	 such	 as	 non‐invasive	 measurement	
of	cardiac	output	or	continuous	monitoring	of	hemoglobin	concen‐
tration	by	pulse	oximetry	may	become	significant	additions	to	NIRS	
monitoring.
5  | CONCLUSION
NIRS	monitoring	can	help	maintain	sufficient	tissue	perfusion/oxy‐
genation	 in	 anesthetized	 children.	Our	 approach	defining	baseline	
awake	 c‐rSO2	 values	 as	 the	 lower	 limit	 is	 fundamentally	 different	
from	previously	 reported	treatment	algorithms	defining	 lower	 lim‐
its	 of	 c‐rSO2	 values	 by	 either	 percentage	 reductions	 compared	 to	
baseline	or	absolute	values	assumed	to	be	associated	with	cerebral	
hypoxemia.	Cerebral	NIRS	monitoring,	interpreted	together	with	its	
continuously	available	contributing	parameters	(BP,	PaCO2,	HR,	and	
SaO2),	may	help	avoid	potentially	harmful	episodes	of	cerebral	de‐
saturation	in	anesthetized	pediatric	patients.
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